Teleflex Incorporated Reports Earnings Results for the Third Quarter and Nine Months Ended September 26, 2021
October 28, 2021 at 10:17 am EDT
Share
Teleflex Incorporated reported earnings results for the third quarter and nine months ended September 26, 2021. For the third quarter, the company reported sales was USD 700.25 million compared to USD 628.3 million a year ago. Net income was USD 199.18 million compared to USD 116.59 million a year ago. Basic earnings per share from continuing operations was USD 4.26 compared to USD 2.51 a year ago. Diluted earnings per share from continuing operations was USD 4.2 compared to USD 2.46 a year ago. Basic earnings per share was USD 4.26 compared to USD 2.51 a year ago. Diluted earnings per share was USD 4.2 compared to USD 2.46 a year ago.
For the nine months, sales was USD 2,047.65 million compared to USD 1,825.98 million a year ago. Net income was USD 357.3 million compared to USD 259.19 million a year ago. Basic earnings per share from continuing operations was USD 7.66 compared to USD 5.58 a year ago. Diluted earnings per share from continuing operations was USD 7.54 compared to USD 5.48 a year ago. Basic earnings per share was USD 7.64 compared to USD 5.58 a year ago. Diluted earnings per share was USD 7.53 compared to USD 5.48 a year ago.
Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows:
- interventional cardiology, radiology and urology products (26.5%);
- vascular access solutions (25.9%);
- surgical devices (12.5%);
- anesthesia products (11.9%);
- other (23.2%).
Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).
TELEFLEX INCORPORATED 
